发布求助
文献互助 智能选刊 最新文献

Im Focus Onkologie最新文献

筛选
英文 中文
Diabetes im mittleren Alter erhöht das Krebsrisiko in späteren Jahren 晚年糖尿病会增加得癌症的风险
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4340-0
B. Schalhorn
{"title":"Diabetes im mittleren Alter erhöht das Krebsrisiko in späteren Jahren","authors":"B. Schalhorn","doi":"10.1007/s15015-018-4340-0","DOIUrl":"https://doi.org/10.1007/s15015-018-4340-0","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"8 1","pages":"22"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74466820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wer ist ... Olaf Ortmann? 谁奥拉夫Ortmann ?
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4401-4
Springer Medizin
{"title":"Wer ist ... Olaf Ortmann?","authors":"Springer Medizin","doi":"10.1007/s15015-018-4401-4","DOIUrl":"https://doi.org/10.1007/s15015-018-4401-4","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"99 1","pages":"83"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72779464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DKTK-Studienregister: Schneller passende Studien finden 物证学院，找到合适的研究
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4377-0
F. Klein
{"title":"DKTK-Studienregister: Schneller passende Studien finden","authors":"F. Klein","doi":"10.1007/s15015-018-4377-0","DOIUrl":"https://doi.org/10.1007/s15015-018-4377-0","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"59 1","pages":"72-73"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85511740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lokaler Prostatakrebs: Brachytherapie langfristig sinnvoll für alle Risikogruppen 早期前列腺癌，所有面临危险的人都有长期的预防性治疗
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4376-1
B. Kreutzkamp
{"title":"Lokaler Prostatakrebs: Brachytherapie langfristig sinnvoll für alle Risikogruppen","authors":"B. Kreutzkamp","doi":"10.1007/s15015-018-4376-1","DOIUrl":"https://doi.org/10.1007/s15015-018-4376-1","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"14 1","pages":"71"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82633556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PRO: Belastende Symptome bei Krebspatienten zeitnah erfassen 临床癌症患者的症状
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4344-9
E. Oberhofer
{"title":"PRO: Belastende Symptome bei Krebspatienten zeitnah erfassen","authors":"E. Oberhofer","doi":"10.1007/s15015-018-4344-9","DOIUrl":"https://doi.org/10.1007/s15015-018-4344-9","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"1 1","pages":"27"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88574561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triple-negatives Mammakarzinom: Immuntherapie first-line wirksam 三阴性Mammakarzinom:免疫治疗一线工作人员
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4394-z
P. Stiefelhagen
{"title":"Triple-negatives Mammakarzinom: Immuntherapie first-line wirksam","authors":"P. Stiefelhagen","doi":"10.1007/s15015-018-4394-z","DOIUrl":"https://doi.org/10.1007/s15015-018-4394-z","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"60 1","pages":"80 - 80"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77163452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NSCLC: Tyrosinkinasehemmer mit hoher ZNS-Wirksamkeit 快点，lc，泰洛欣警报
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4345-8
J. Neumaier
{"title":"NSCLC: Tyrosinkinasehemmer mit hoher ZNS-Wirksamkeit","authors":"J. Neumaier","doi":"10.1007/s15015-018-4345-8","DOIUrl":"https://doi.org/10.1007/s15015-018-4345-8","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"1 1","pages":"30"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86268583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapie des EGFR-mutierten NSCLC 改变记忆的NSCLC
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4383-2
G. Springer
{"title":"Therapie des EGFR-mutierten NSCLC","authors":"G. Springer","doi":"10.1007/s15015-018-4383-2","DOIUrl":"https://doi.org/10.1007/s15015-018-4383-2","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"30 1","pages":"77 - 77"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81150121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Die besten Innovationen 2018 2018年最好的创新
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4382-3
C. Heyer
{"title":"Die besten Innovationen 2018","authors":"C. Heyer","doi":"10.1007/s15015-018-4382-3","DOIUrl":"https://doi.org/10.1007/s15015-018-4382-3","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"15 1","pages":"76"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91474350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Doppelte HER2-Blockade beim HER2-positivem Mammakarzinom
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4386-z
Red.
{"title":"Doppelte HER2-Blockade beim HER2-positivem Mammakarzinom","authors":"Red.","doi":"10.1007/s15015-018-4386-z","DOIUrl":"https://doi.org/10.1007/s15015-018-4386-z","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"77 1","pages":"78 - 78"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86930497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信